Livzon Pharmaceutical Group Inc.

SZSE:000513 Stock Report

Market Cap: CN¥30.2b

Livzon Pharmaceutical Group Balance Sheet Health

Financial Health criteria checks 5/6

Livzon Pharmaceutical Group has a total shareholder equity of CN¥14.9B and total debt of CN¥4.1B, which brings its debt-to-equity ratio to 27.4%. Its total assets and total liabilities are CN¥24.9B and CN¥10.0B respectively. Livzon Pharmaceutical Group's EBIT is CN¥2.4B making its interest coverage ratio -12.8. It has cash and short-term investments of CN¥10.8B.

Key information

27.4%

Debt to equity ratio

CN¥4.09b

Debt

Interest coverage ratio-12.8x
CashCN¥10.81b
EquityCN¥14.94b
Total liabilitiesCN¥9.97b
Total assetsCN¥24.91b

Recent financial health updates

Recent updates

We Think You Can Look Beyond Livzon Pharmaceutical Group's (SZSE:000513) Lackluster Earnings

Aug 30
We Think You Can Look Beyond Livzon Pharmaceutical Group's (SZSE:000513) Lackluster Earnings

Livzon Pharmaceutical Group Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 26
Livzon Pharmaceutical Group Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

A Look At The Fair Value Of Livzon Pharmaceutical Group Inc. (SZSE:000513)

Aug 09
A Look At The Fair Value Of Livzon Pharmaceutical Group Inc. (SZSE:000513)

Livzon Pharmaceutical Group (SZSE:000513) Is Paying Out Less In Dividends Than Last Year

Jul 02
Livzon Pharmaceutical Group (SZSE:000513) Is Paying Out Less In Dividends Than Last Year

We Think The Compensation For Livzon Pharmaceutical Group Inc.'s (SZSE:000513) CEO Looks About Right

Jun 07
We Think The Compensation For Livzon Pharmaceutical Group Inc.'s (SZSE:000513) CEO Looks About Right

Livzon Pharmaceutical Group Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Apr 26
Livzon Pharmaceutical Group Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Does Livzon Pharmaceutical Group (SZSE:000513) Have A Healthy Balance Sheet?

Apr 21
Does Livzon Pharmaceutical Group (SZSE:000513) Have A Healthy Balance Sheet?

Is Now The Time To Put Livzon Pharmaceutical Group (SZSE:000513) On Your Watchlist?

Mar 15
Is Now The Time To Put Livzon Pharmaceutical Group (SZSE:000513) On Your Watchlist?

Financial Position Analysis

Short Term Liabilities: 000513's short term assets (CN¥16.6B) exceed its short term liabilities (CN¥9.0B).

Long Term Liabilities: 000513's short term assets (CN¥16.6B) exceed its long term liabilities (CN¥960.3M).


Debt to Equity History and Analysis

Debt Level: 000513 has more cash than its total debt.

Reducing Debt: 000513's debt to equity ratio has increased from 0% to 27.4% over the past 5 years.

Debt Coverage: 000513's debt is well covered by operating cash flow (81.7%).

Interest Coverage: 000513 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies